MRI - Guided Adaptive RadioTHerapy for Reducing XerostomiA in Head and Neck Cancer (MARTHA-trial) | MicrobiomeTrials← Back to trialsNCT03972072
MRI - Guided Adaptive RadioTHerapy for Reducing XerostomiA in Head and Neck Cancer (MARTHA-trial)
CompletedNAINTERVENTIONAL
Trial Details
Start: 2019-10-15Est. Completion: 2025-05-21
Enrollment target: 49 participants Locations- Zurich University Hospital, Zurich, Switzerland
Other microbiome trials you might be interested in
Oesophageal Squamous Cell CarcinomaOesophageal AdenocarcinomaGastric AdenocarcinomaPancreatic Ductal Adenocarcinoma (PDAC)CholangiocarcinomaHepatocellular Carcinoma (HCC)Colorectal Adenocarcinoma
The investigators of this study are developing a simple breath test to help detect gastrointestinal (gut) cancers earlie…
Maidstone, United KingdomEst. completion Feb 2, 2028
Parathyroid CancerPrimary HyperparathyroidismPseudohypoparathyroidismInheritable Bone Diseases
Multiple Endocrine Neoplasia, Type 1
Background:
Parathyroid disorders are very common in the general population and include disorders of parathyroid excess…
Bethesda, United StatesEst. completion Jan 22, 2031
Thyroid Nodule
In this study, a randomized controlled study was conducted between two groups of 40 recipients of conventional flap duri…
Busan, South KoreaEst. completion Jun 30, 2024